SUSMED, Inc. [4263.T]

TOKYO, May 08 (Pulse News Wire) – Susmed, Inc. (4263.T) reported non-consolidated results for Q3 FY2026 (ending June 2026).

Revenue was ¥230 million (+44.9% YoY). operating profit was ¥345 million.

Net profit was ¥332 million. Total assets stood at ¥4.2 billion with an equity ratio of 95.3%.

Financial results — FY2026/6 (consolidated)

MetricCurrentYoY
Revenue¥230M-44.9%
Operating profit¥-345Mn/a
Net profit¥-332Mn/a

Source: TDNet filing · Figures in millions of yen

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.